Document Detail

The new patent foramen ovale occluder FIGULLA in complex septal anatomy. A case series.
MedLine Citation:
PMID:  23238514     Owner:  NLM     Status:  Publisher    
BACKGROUND: The appropriate treatment strategy for secondary stroke prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) remains challenging. The aim of this study was to describe a case series of patients with PFO and complex septal anatomy who underwent percutaneous correction using a FIGULLA (Occlutech®) septal occluder (FSO).Patients: Ten consecutive patients (6 females, 4 males, mean age 41.6 ± 16.0 years, range 17-52 years; Group 1) with cryptogenetic stroke and/or transient cerebral ischemia and complex septal anatomy, as defined by intraprocedural transesophageal echocardiogram (TEE) were compared with a group of 25 patients (10 females, 15 males, mean age 43.7 ± 12.3 years; Group 2) with usual tunnel-like PFO anatomy in whom PFO was closed by an Amplatzer septal occluder (ASO; AGA®). RESULTS: No significant differences were noted between Group 1 and Group 2 for immediate success rate, residual intraprosthetic shunt at the end of the procedure, discharge, 1, 6 and 12 months follow up, number of attempts, procedure time, fluoroscopy time, or cardiac complication (atrial arrhythmias, device embolism).The only significant difference was shown for delivery sheath size (11 ± 2 versus 9 ± 1 F) and incidence of local hematoma (30% versus 12 %) between Group 1 and Group 2, without any clinical consequence (need of transfusion) or increase in length of stay. CONCLUSION: FSO shows high performance in patients with PFO and complex septal anatomy when compared with patients with PFO and uncomplicated atrial anatomy treated by ASO. Its favorable behavior is probably related to fabric features such as the total amount of metal and the presence of titanium.
Roberto Baglini; Duccio Baldari; Andrea Amaducci; Giuseppe D'Ancona
Related Documents :
7149614 - Splenectomy for myelofibrosis.
15136214 - Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia i...
8472144 - Splenectomy for splenomegaly exceeding 1000 grams: analysis of 47 patients.
24361984 - Gender influence on the outcome of an unisex total knee arthroplasty system.
18931544 - Urethral reconstruction in balanitis xerotica obliterans.
20083264 - Risk factor analysis in a contemporary cystectomy cohort using standardized reporting m...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-13
Journal Detail:
Title:  Therapeutic advances in cardiovascular disease     Volume:  -     ISSN:  1753-9455     ISO Abbreviation:  Ther Adv Cardiovasc Dis     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101316343     Medline TA:  Ther Adv Cardiovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Interventional Cardiology, IsMeTT, University of Pittsburgh European Centre, Palermo, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The association between referral source and outcome in patients with colorectal cancer.
Next Document:  Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk?